JD.com (JD) Stock Looks Reasonable On Earnings While Returns Stay Weak

JD.com stock sits in an unusual spot today, with a share price around US$30.60 and a five year return that has fallen 47.3%, yet the valuation checks still suggest the shares lean cheap rather than expensive.

  • Over the past five years JD.com has delivered a 47.3% decline, which means any hint of undervaluation is coming after a long period of weak shareholder returns rather than a recent rally.
  • Recent commentary around profit growth expectations and ongoing regulatory and legal scrutiny can both influence how much investors are willing to pay for JD.com’s earnings and cash flows.
  • JD.com screens as undervalued on 5 of 6 valuation checks. This means the broader set of metrics points to a stock that still looks cheap on fundamentals rather than fully priced according to 5.

The stock’s next move may depend on whether the discounted share price is a fair reflection of JD.com’s risks or an opportunity relative to its underlying financial profile.

Find out why JD.com's -5.2% return over the last year is lagging behind its peers.

Advertisement

Is JD.com Still Cheap on Earnings?

The P/E ratio is a useful way to look at JD.com because it anchors the stock price to the earnings that shareholders care about most.

JD.com trades on a P/E of 20.2x, which sits close to the Multiline Retail industry average of 19.4x but well below the peer group average of 30.7x. On Simply Wall St’s fair ratio framework, which looks at factors such as JD.com’s growth profile, margins, size and risk, a P/E closer to 33.0x would be typical, so the current market multiple is meaningfully lower than that reference point.

Despite recent headlines around a regulatory investigation into alleged false advertising, the current pricing still leaves JD.com at a discount to what this fair P/E yardstick implies. For investors comparing it with both its industry and peers, the earnings multiple suggests the stock is not fully reflecting the earnings power implied by that model.

On the P/E multiple alone, JD.com stock appears undervalued relative to the fair ratio implied by its fundamentals.

NasdaqGS:JD P/E Ratio as at Jul 2026
NasdaqGS:JD P/E Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The JD.com Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for JD.com sit between the current valuation puzzle and the assumptions that would need to hold on JD.com's growth, margins and earnings for the stock to be worth materially more or less than today’s price, and they are found on the Community page. Each narrative links a fair value to a specific mix of potential catalysts and risks, so you can track which version of JD.com's story appears to be unfolding over time.

Community views on JD.com sit far apart, with one camp focused on what its logistics engine could deliver and the other on how much those same investments might cost.

Bull case: 32% undervalued

"Ongoing investments in logistics, automation, and supply chain optimization continue to reduce procurement costs, improve fulfillment efficiencies, and expand margins in the core retail segment..."

Read the full Bull Case to see why JD.com could be undervalued

Bear case: 14% overvalued

"JD.com's heavy investment in food delivery and other new businesses is leading to widening operating losses in these segments, with non-GAAP operating loss in new business reaching RMB 14.8 billion this quarter..."

Read the full Bear Case to see why JD.com could be overvalued

Do you think there's more to the story for JD.com? Head over to our Community to see what others are saying!

The Bottom Line

JD.com still screens as undervalued on market multiples, with the current P/E sitting below the level suggested by the fair ratio framework and below its peer group reference point. The key question is whether that discount reflects temporary caution around regulation and new business investment, or a more durable concern about how much profit those initiatives can ultimately deliver. For now, the gap between what the multiples imply and what the market is willing to pay largely comes down to confidence in JD.com's margin trajectory and the eventual payoff from its logistics and new business spending.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:JD

JD.com

Operates as a supply chain-based technology and service provider in the People’s Republic of China and Europe.

Undervalued with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
66 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0